Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Metab Cardiovasc Dis ; 16(2): 121-7, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16487912

ABSTRACT

BACKGROUND AND AIM: Dyslipidemia is one of the main risk factors for atherosclerosis, usually the underlying cause of cardiovascular diseases which are the major cause of morbidity and mortality in developed countries. The aim of this study was to assess the effects and the advantages of a combined dietary supplementation with PUFA n-3, vitamin E, niacin and gamma-oryzanol on lipid profile, inflammatory status and oxidative balance. METHODS AND RESULTS: Fifty-seven dyslipidemic volunteers were randomly assigned to receive: placebo (group A, 19 subjects); PUFA n-3 and vitamin E (group B, 18 subjects); the same as B plus gamma-oryzanol and niacin (group C, 20 subjects). Lipid profile, reactive oxygen species (ROS), total antioxidant capacity (TAC), vitamin E, interleukin 1-beta (IL1-beta), tumor necrosis factor (TNF-alpha) and thromboxane B2 (TXB2) were determined at baseline (T0) and after four months (T1). All dyslipidemic subjects showed, at baseline, oxidative stress and, after four months, all biochemical markers improved significantly in groups treated with dietary supplementation. Particularly in group C all lipid patterns improved significantly. CONCLUSIONS: Our findings demonstrate that the strategy of combining different compounds, which protect each other and act together at different levels of the lipid chain production, improves lipid profile, inflammatory and oxidative status, allowing us to reduce the dose of each compound under the threshold of its side effects.


Subject(s)
Antioxidants/therapeutic use , Hyperlipidemias/drug therapy , Hypolipidemic Agents/therapeutic use , Lipid Metabolism/drug effects , Oxidative Stress/drug effects , Adult , Aged , Antioxidants/administration & dosage , Atherosclerosis/epidemiology , Atherosclerosis/etiology , Cytokines/metabolism , Dietary Supplements , Drug Therapy, Combination , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/therapeutic use , Female , Humans , Hyperlipidemias/complications , Hypolipidemic Agents/administration & dosage , Inflammation Mediators/metabolism , Male , Middle Aged , Niacin/administration & dosage , Niacin/therapeutic use , Oxidation-Reduction , Phenylpropionates/administration & dosage , Phenylpropionates/therapeutic use , Reactive Oxygen Species/metabolism , Risk Factors , Vitamin E/administration & dosage , Vitamin E/therapeutic use
2.
Mutagenesis ; 12(5): 329-33, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9379910

ABSTRACT

We employed the three-way differential staining technique (TWD), which allows SCEs to be distinguished on a per generation basis by scoring third metaphases (M3), in order to study the spontaneous levels of SCEs in normal and high frequency cells (HFCs) that occurred in the first (S1), second (S2) and third (S3) S phases. Fifty one of 900 lymphocytes from 37 healthy donors were defined as HFCs by calculating the 95th percentile of the distribution of SCEs in S1 + S2. 'Normal' cells presented almost the same number of SCEs after the first, second and third cell cycles (SCE averages of 2.43, 2.04 and 3.53 respectively). In contrast, HFCs showed a higher SCE count in S1, which decreased rapidly through the cycles and reached baseline level at S3 (SCE averages of 7.18, 4.29 and 3.45 respectively). This would suggest that the lesions responsible for the higher SCE frequency in HFCs were effectively removed after two cell cycles and strongly support the hypothesis that HFCs are lymphocytes which accumulate higher levels of DNA lesions through time.


Subject(s)
Lymphocytes/cytology , Sister Chromatid Exchange , Adolescent , Adult , Aged , Aged, 80 and over , Cell Cycle , Cells, Cultured , Child , Female , Humans , Male , Middle Aged , Reference Values , Sex Characteristics
3.
Mutagenesis ; 11(5): 467-9, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8921508

ABSTRACT

As humic compounds are naturally widespread in the environment and present in surface water, studies on their genotoxicity are justified. Humic acid (HA) has not been demonstrated to be genotoxic either in vitro or in vivo. In the present paper we investigated its activity both in intestinal and bone marrow cells following a single dose (100 mg/kg b.w. corresponding to 0.5 ml per animal of an aqueous solution of 4 g/l) of HA administered to mice by gastric intubation, to mimic the most likely route of human exposure. HA induced structural and, in particular, numerical chromosome abnormalities in intestinal cells. A marginal, non-significant induction of aneuploidy was also found in bone marrow cells.


Subject(s)
Bone Marrow/drug effects , Chromosome Aberrations , Humic Substances/pharmacology , Intestines/drug effects , Mutagens/pharmacology , Aneuploidy , Animals , Epithelial Cells , Epithelium/drug effects , Humic Substances/chemistry , Intestine, Small/cytology , Intestine, Small/drug effects , Intestines/cytology , Intubation, Gastrointestinal/methods , Male , Mice , Mutagenicity Tests/methods , Spindle Apparatus/drug effects , Structure-Activity Relationship
4.
Mutat Res ; 369(1-2): 107-12, 1996 Jul 10.
Article in English | MEDLINE | ID: mdl-8700175

ABSTRACT

Two coal-derived humic substances (Sulcis and South Africa, Eniricerche, Italy) have been evaluated for their mutagenic activity on TA98 and TA100 Salmonella typhimurium strains, either in presence or in absence of metabolic activation (S9). Both compounds showed no effect on the two strains, as observed with natural humic acid (Fluka). After chlorination, coal-derived humic acids induced a strong dose-related increase in the number of revertants on TA100 without S9, whose extent was directly proportional to the chlorination ratios. Such effect was completely suppressed when a sodium thiosulfate solution (10%) was added at the end of the chlorination period (about 90 h). The analogies with natural humic acid mutagenicity are discussed.


Subject(s)
Coal , Humic Substances/toxicity , Mutagens/toxicity , Salmonella typhimurium/genetics , Antimutagenic Agents/pharmacology , Dose-Response Relationship, Drug , Thiosulfates/pharmacology
5.
Mutagenesis ; 9(6): 505-15, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7854141

ABSTRACT

Micronucleus (Mn) and metaphase chromosome analyses were performed in mouse bone marrow cells with two known and eight suspected mitotic spindle poisons. Polychromatic (PCEs) and normochromatic (NCEs) erythrocytes were scored for presence of Mn, while structural (CAs) and numerical chromosome aberrations (NCAs), i.e. hyperploid cells, were evaluated by metaphase analysis. CAs were scored in first, and NCAs in the second metaphases, identified by BrdUrd differential staining. Hydroquinone induced Mn, NCAs and CAs; colchicine, vinblastine and, to a lesser extent, chloral hydrate, diazepam and econazole induced both Mn and NCAs; cadmium chloride and thimerosal induced Mn and CAs, while pyrimethamine and thiabendazole induced Mn only. The proposed stepwise protocol allowed satisfactory statistical evaluation of the effects induced with a reduction in the number of animals killed. An acceptable agreement was found between induction of Mn and NCAs, suggesting a possible use of the Mn test for revealing compounds with aneugenic properties.


Subject(s)
Chromosome Aberrations/physiology , Metaphase , Micronucleus Tests , Spindle Apparatus/drug effects , Animals , Bone Marrow Cells , Cadmium/pharmacology , Cadmium Chloride , Cells, Cultured/drug effects , Chloral Hydrate/pharmacology , Chlorides/pharmacology , Colchicine/pharmacology , Diazepam/pharmacology , Econazole/pharmacology , Hydroquinones/pharmacology , Male , Mice , Pyrimethamine/pharmacology , Thiabendazole/pharmacology , Thimerosal/pharmacology , Vinblastine/pharmacology
6.
Mutat Res ; 271(3): 223-30, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1378195

ABSTRACT

A method for assessing the effect of clastogens on mouse skin epidermal cells was devised and applied. Toxic and mutagenic responses in epidermal cells were tested using two known mutagens and carcinogens, urethane (URE) and 7,12-dimethylbenz[a]anthracene (DMBA). Cell generation time, sister-chromatid exchanges (SCE) and chromosomal aberrations (CA) after topical and intraperitoneal (i.p.) treatment were measured in epidermal and bone marrow cells. After topical administration both tissues responded similarly, whereas after i.p. treatment skin cells were less responsive than bone marrow cells. However, the results indicate the validity of this new cytogenetic approach for the assessment of the genotoxicity of compounds applied directly to skin.


Subject(s)
Carcinogenicity Tests/methods , Mutagenicity Tests/methods , Skin/drug effects , 9,10-Dimethyl-1,2-benzanthracene/administration & dosage , 9,10-Dimethyl-1,2-benzanthracene/toxicity , Administration, Topical , Animals , Bone Marrow/drug effects , Cell Cycle/drug effects , Chromosome Aberrations , Karyotyping , Male , Mice , Sister Chromatid Exchange/drug effects , Urethane/administration & dosage , Urethane/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...